Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Causes and consequences of obesity: epigenetics or hypokinesis?

Graham MR, Baker JS, Davies B.

Diabetes Metab Syndr Obes. 2015 Sep 16;8:455-60. doi: 10.2147/DMSO.S82629. eCollection 2015. No abstract available.

2.

Interaction of dietary fat intake with APOA2, APOA5 and LEPR polymorphisms and its relationship with obesity and dyslipidemia in young subjects.

Domínguez-Reyes T, Astudillo-López CC, Salgado-Goytia L, Muñoz-Valle JF, Salgado-Bernabé AB, Guzmán-Guzmán IP, Castro-Alarcón N, Moreno-Godínez ME, Parra-Rojas I.

Lipids Health Dis. 2015 Sep 13;14:106. doi: 10.1186/s12944-015-0112-4.

5.

The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.

Garelnabi M, Lor K, Jin J, Chai F, Santanam N.

Clin Biochem. 2013 Jan;46(1-2):12-9. doi: 10.1016/j.clinbiochem.2012.09.007. Epub 2012 Sep 19. Review.

6.

APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial.

Zhang X, Qi Q, Bray GA, Hu FB, Sacks FM, Qi L.

Am J Clin Nutr. 2012 Oct;96(4):917-22. Epub 2012 Aug 22.

7.

Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach.

Curti ML, Jacob P, Borges MC, Rogero MM, Ferreira SR.

J Obes. 2011;2011:497401. doi: 10.1155/2011/497401. Epub 2011 May 23.

8.

The PLIN4 variant rs8887 modulates obesity related phenotypes in humans through creation of a novel miR-522 seed site.

Richardson K, Louie-Gao Q, Arnett DK, Parnell LD, Lai CQ, Davalos A, Fox CS, Demissie S, Cupples LA, Fernandez-Hernando C, Ordovas JM.

PLoS One. 2011 Apr 20;6(4):e17944. doi: 10.1371/journal.pone.0017944.

9.

APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population.

Sánchez-Moreno C, Ordovás JM, Smith CE, Baraza JC, Lee YC, Garaulet M.

J Nutr. 2011 Mar;141(3):380-5. doi: 10.3945/jn.110.130344. Epub 2011 Jan 5.

10.

Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease.

Park JY, Paik JK, Kim OY, Chae JS, Jang Y, Lee JH.

J Lipid Res. 2010 Nov;51(11):3281-8. doi: 10.1194/jlr.M010330. Epub 2010 Aug 27.

11.

Nutrigenomics in cardiovascular medicine.

Corella D, Ordovas JM.

Circ Cardiovasc Genet. 2009 Dec;2(6):637-51. doi: 10.1161/CIRCGENETICS.109.891366. Review. No abstract available.

12.

APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations.

Corella D, Peloso G, Arnett DK, Demissie S, Cupples LA, Tucker K, Lai CQ, Parnell LD, Coltell O, Lee YC, Ordovas JM.

Arch Intern Med. 2009 Nov 9;169(20):1897-906. doi: 10.1001/archinternmed.2009.343.

13.

Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults.

Mattei J, Demissie S, Tucker KL, Ordovas JM.

J Nutr. 2009 Dec;139(12):2301-8. doi: 10.3945/jn.109.109900. Epub 2009 Oct 14.

14.

Apolipoprotein A5 and lipoprotein lipase interact to modulate anthropometric measures in Hispanics of Caribbean origin.

Smith CE, Tucker KL, Lai CQ, Parnell LD, Lee YC, Ordovás JM.

Obesity (Silver Spring). 2010 Feb;18(2):327-32. doi: 10.1038/oby.2009.216. Epub 2009 Jul 23.

15.

Overexpression of apolipoprotein A5 in mice is not protective against body weight gain and aberrant glucose homeostasis.

Pamir N, McMillen TS, Li YI, Lai CM, Wong H, LeBoeuf RC.

Metabolism. 2009 Apr;58(4):560-7. doi: 10.1016/j.metabol.2008.11.018.

16.

ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study.

Warodomwichit D, Shen J, Arnett DK, Tsai MY, Kabagambe EK, Peacock JM, Hixson JE, Straka RJ, Province MA, An P, Lai CQ, Parnell LD, Borecki IB, Ordovas JM.

Obesity (Silver Spring). 2009 Mar;17(3):510-7. doi: 10.1038/oby.2008.583. Epub 2008 Dec 18.

17.

Public health genomics: translating obesity genomics research into population health benefits.

Agurs-Collins T, Khoury MJ, Simon-Morton D, Olster DH, Harris JR, Milner JA.

Obesity (Silver Spring). 2008 Dec;16 Suppl 3:S85-94. doi: 10.1038/oby.2008.517.

18.

The challenges for molecular nutrition research 1: linking genotype to healthy nutrition.

Williams CM, Ordovas JM, Lairon D, Hesketh J, Lietz G, Gibney M, van Ommen B.

Genes Nutr. 2008 Jul;3(2):41-9. doi: 10.1007/s12263-008-0086-1.

19.

Clinical significance of apolipoprotein A5.

Tai ES, Ordovas JM.

Curr Opin Lipidol. 2008 Aug;19(4):349-54. doi: 10.1097/MOL.0b013e328304b681. Review.

20.
Items per page

Supplemental Content

Write to the Help Desk